secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuroPace Inc (NPCE)
CIK:        0001528287
Form:       8-K
Filed at:   2021-09-09T23:59:59+00:00
Accession:  0001528287-21-000013
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroPace warns Q3 revenue uncertainty due to COVID-19 Delta variant procedure delays
--------------------------------------------------------------------------------

- Procedure volumes impacted in Q3 due to scheduling delays from COVID-19 Delta variant.
- Management believes delays will create uncertainty around revenue for second half of 2021.
- Company to participate in three healthcare conferences: Wells Fargo, Morgan Stanley, Baird.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1528287/000152828721000013/0001528287-21-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1528287/000152828721000013/npce-20210909.htm
  HTML page:      https://secwatch.observer/filing/0001528287-21-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer